Inside Russia's $26 Billion State-Backed Longevity Program: Bioprinting, Gene Therapy, and the Politics of Anti-Aging Research
核心洞察
Russia's New Health Preservation Technologies program carries a $26 billion price tag and focuses on gene therapy, organ bioprinting, xenotransplantation, and ultralow temperature exposure.
The program promises to save 175,000 lives by the end of the decade, a figure that roughly matches independent estimates of Russian troop losses from the Ukraine invasion.
Russian researchers claim to have bioprinted human cartilage and a mouse thyroid gland, but the program has produced little peer-reviewed research in major international journals.
A conversation between Vladimir Putin and Xi Jinping, inadvertently captured on a live broadcast during a military parade in Beijing in September 2025, has drawn renewed scrutiny to one of the most ambitious and politically charged scientific undertakings in modern Russia: a roughly $26 billion national program aimed at extending healthy human life.
According to The Wall Street Journal, Russia's New Health Preservation Technologies program encompasses gene therapy, organ bioprinting, xenotransplantation, and exposure to ultralow temperatures. The initiative promises to save 175,000 lives by the end of the decade — a figure the Journal noted carries an uncomfortable echo, as it roughly matches independent estimates of Russian troop losses from the invasion of Ukraine.
During the Beijing parade, Putin's interpreter was heard speaking of biotechnology, constant organ transplants, and the possibility that people could become younger, "perhaps even achieve immortality." A voice later referred to predictions that humans might one day live to 150. Putin subsequently confirmed to reporters that longevity had been discussed with Xi.
The Inner Circle Driving the Science
The Wall Street Journal reported that two figures close to Putin sit near the center of the initiative: Maria Vorontsova, his elder daughter and an endocrinologist involved in state-backed genetics programs, and Mikhail Kovalchuk, the physicist who leads the Kurchatov Institute (搜索).
Kovalchuk's brother Yuri Kovalchuk is a banker and media investor long described as close to Putin. Mikhail Kovalchuk has argued for years that science will allow the human body to be repaired and renewed, with worn parts replaced over time. The Kremlin version of longevity research, the Journal noted, grows inside the same personal network that surrounds Putin's power.
The Science: Bioprinting and Xenotransplantation
Russian state scientists are focusing on two headline technologies. Bioprinting uses 3D printing techniques to build living tissue, and Russian researchers claim to have printed human cartilage and a mouse thyroid gland. Xenotransplantation aims to grow human-compatible organs inside genetically modified mini-pigs, with the goal of human organ replacement by 2030 under discussion.
A gene-therapy treatment intended to slow cellular aging has also drawn attention. Deputy Science Minister Denis Sekirinsky said on April 23 that the drug was one of the most promising routes in the fight against aging, according to the Journal. The Moscow Times separately reported that Russian officials announced an experimental gene-therapy drug in April 2026, designed to block a receptor associated with age-related cellular changes.
A Thin Public Record
Despite the scale of investment, the program's scientific output remains largely opaque. The Wall Street Journal reported that Putin's longevity circle has produced little peer-reviewed research in major international journals. Alexander Ostrovskiy, a Russian bioprinting pioneer who left the country after the 2022 invasion of Ukraine, told the paper that without publications there are no real results, only aspirations. He also warned that science cannot work properly in isolation.
That warning carries weight given that Russian science is operating under sanctions, political pressure, and a culture where telling the leader what he wants to hear can be safer than telling him what is true.
Personal Claims and Speculation
The Daily Express has separately linked Putin to deer-blood treatments and genetically modified strawberries containing elevated levels of quercetin. However, no public clinical evidence shows that either practice would extend life, raise testosterone, or produce the other benefits attributed to them. As Dagens.com noted, claims that the longevity program proves Putin is pursuing personal immortality remain speculative.
Putin is 73. For decades, he has cultivated images of physical strength through staged displays of stamina. The longevity project, observers suggest, represents the same instinct — now with laboratories attached. Whether Russia prints a working human organ by 2030 remains an open question. The more immediate question is what kind of government turns one ruler's anxiety about age into a flagship state program while young citizens are being spent in war.